Glenmark launches generic Lacosamide Injection USP in US Market
Company expands injectable portfolio with therapeutically equivalent version of Vimpat®, targeting a market valued at approximately $15.2 million annually
Company expands injectable portfolio with therapeutically equivalent version of Vimpat®, targeting a market valued at approximately $15.2 million annually
MSD joins as anchor customer as Aurobindo strengthens its position in the fast-growing global biologics manufacturing market
The ventilator features a high-performance turbine capable of delivering up to 240 L/min peak flow
Dr. Lall brings extensive experience in healthcare operations, business strategy, and hospital management
Specialised clinic to offer regular device monitoring, battery assessment, rhythm evaluation, and expert cardiac electrophysiology consultation
Day-care model aimed at providing specialized psychological support for women during pregnancy and motherhood
The facility integrates advanced scientific infrastructure and specialised workflows to support complex drug delivery systems, sterile injectables, and differentiated dosage forms
Dr. Rishi brings more than 15 years of experience in bioprocess development, microbial fermentation, technology transfer, and biotechnology operations
The move signals a major expansion in access to next-generation weight-loss therapies
Veteran pharmaceutical executive to relocate to Saudi Arabia and spearhead Cipla’s growth strategy across the Middle East region
Subscribe To Our Newsletter & Stay Updated